{"id":120523,"name":"PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION","slug":"pharmaceutical-industry-labor-management-association","state":null,"description":null,"totalSpending":1560000,"filings":26,"yearlySpending":[{"year":2018,"income":180000},{"year":2019,"income":180000},{"year":2020,"income":180000},{"year":2021,"income":240000},{"year":2022,"income":240000},{"year":2023,"income":240000},{"year":2024,"income":240000},{"year":2025,"income":60000}],"firms":["FLYNN & ASSOCIATES, INC."],"lobbyists":["JOHN FLYNN"],"issues":["PHA",null],"sampleDescriptions":["Childrens Health Insurance Program\nImportation of drugs from Canada","Childrens Health Insurance Program\nImportation of drugs from Canada\nMedicare Part D - Rebates","HR. 1344 Competitive DRUGS Act of 2019","HR. 1344 Competitive DRUGS Act of 2019\nDrug importation from Canada","Drug importation from Canada\nHR 3 Lower Drug Costs Now Act of 2019","H.R. 3 Lower Drug Prices- Cummings Act\nDrug importation from Canada","ACA Stabilization - Drug Pricing\nDrug importation from Canada","Drug Price controls\nDrug importation from Canada","H.R. 3 -  Price controls for prescription drugs.","H.R. 3 -  Price controls for prescription drugs.\nImportation of drugs from other countries.","Price controls for prescription drugs.\nImportation of drugs from other countries.\nBuild Back Better Act (Medicare Part D negotiations).","Price controls for prescription drugs. Importation of drugs from other countries. Prescription Drug User Fee Act (reauthorization).","Drug importation Price controls Pharmacy Benefit Manager issues","Drug importation Price controls Pharmacy Benefit Manager issues HR 2880 and HR 6283","PBM Price Reforms,"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}